Presentation
Dear Colleague,
After the huge success of our 2nd edition of CTAD09 this past October in Las Vegas, we are proud to present our exciting preliminary program for our 3rd edition CTAD which will take place in Toulouse, France on November 3-5, 2010.
As you know the aims of this International Conference are to bring together the current leaders involved in clinical trials on Alzheimer's Disease to discuss new results, new drugs development and future methodological issues (disease modifying outcomes, biomarkers, impact on the Healtcare economy...)
Please note that the call for abstract has been opened since January 2010 and the deadline for submitting an abstract is June 30th 2010.
Looking forward to seeing you in Toulouse next year!!
Paul Aisen, Zaven Kachaturian, Jacques Touchon, Bruno Vellas, Michael Weiner
Scientific Committee
Paul AISEN (San Diego)
Kaj BLENNOW (Molndal)
Merce BOADA (Barcelona)
Maria CARRILLO (Chicago)
Bruno DUBOIS (Paris)
Howard FELDMAN (Vancouver)
Giovanni B. FRISONI (Brescia)
Lutz FROELICH (Mannheim)
Serge GAUTHIER (Montreal)
Ezio GIACOBINI (Geneva)
Michael GRUNDMANN (San Diego)
Zaven KHACHATURIAN (Washington DC)
Virginia LEE (Philadelphia)
Jean-Marc ORGOGOZO (Bordeaux)
Ronald PETERSEN (Minnesota)
Lon SCHNEIDER (Los Angeles)
Eric SIEMERS (Philadelphia)
Peter SNYDER (Rhode Island)
Yaakov STERN (New York)
Jacques TOUCHON (Montpellier)
John TROJANOWSKI (Philadelphia)
Bruno VELLAS (Toulouse)
Michael W. WEINER (San Francisco)
Bengt WINBLAD (Stockholm)
Organizing Committee
Paul AISEN
Merce BOADA
Zaven KACHATURIAN
Jacques TOUCHON
Bruno VELLAS
Michael WEINER
Congress secretariat
ANT Congrès
154 avenue de Lodève
34070 Montpellier
France
E-mail :
Tel : + 33 (0)4 67 10 92 23
ANT Congrès - 154 avenue de Lodève - 34070 Montpellier - France
E-mail : ctad@ant-congres.com
Tel : + 33 (0) 6 85 54 70 98
Fax : + 33 (0)4 67 10 92 23